Composition: Gefitinib 250mg
Availability of this product will assure once the Pharmacy partners is confirmed.
Gefimipsa 250mg capsule is used in the treatment of small cell lung cancer.
In patients with cancer, a change in DNA (genetic material) triggers a signal which produces abnormal cancer cells. Gefimipsa 250mg capsule blocks this signal, and thus stops the production of these cancer cells.
Nausea, Rash, Vomiting, Weakness, Loss of appetite, Dry skin, Diarrhoea, Stomatitis (Inflammation of the mouth).